A detailed history of Schroder Investment Management Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Schroder Investment Management Group holds 1,681,213 shares of LLY stock, worth $1.34 Billion. This represents 1.58% of its overall portfolio holdings.

Number of Shares
1,681,213
Previous 1,833,949 8.33%
Holding current value
$1.34 Billion
Previous $1.66 Billion 10.3%
% of portfolio
1.58%
Previous 1.89%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $118 Million - $147 Million
-152,736 Reduced 8.33%
1,681,213 $1.49 Billion
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $206 Million - $258 Million
-284,014 Reduced 13.41%
1,833,949 $1.66 Billion
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $39.5 Million - $52.9 Million
-66,775 Reduced 3.06%
2,117,963 $1.65 Billion
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $60.6 Million - $71.4 Million
-115,293 Reduced 5.01%
2,184,738 $1.27 Billion
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $45.9 Million - $63.2 Million
-105,480 Reduced 4.38%
2,300,031 $1.24 Billion
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $30.8 Million - $41.2 Million
87,902 Added 3.79%
2,405,511 $1.13 Billion
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $12.1 Million - $14.2 Million
38,883 Added 1.71%
2,317,609 $796 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $32.3 Million - $37.7 Million
-100,524 Reduced 4.23%
2,278,726 $834 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $152 Million - $173 Million
512,160 Added 27.43%
2,379,250 $769 Million
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $35.8 Million - $42.1 Million
-128,595 Reduced 6.44%
1,867,090 $603 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $2.84 Million - $3.52 Million
12,081 Added 0.61%
1,995,685 $579 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $67.2 Million - $83.3 Million
298,659 Added 17.73%
1,983,604 $548 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $60.1 Million - $74 Million
-271,352 Reduced 13.87%
1,684,945 $389 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $23.8 Million - $30.8 Million
131,922 Added 7.23%
1,956,297 $449 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $60.7 Million - $78.6 Million
-369,652 Reduced 16.85%
1,824,375 $341 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $38 Million - $50.2 Million
291,000 Added 15.29%
2,194,027 $370 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $30 Million - $34.7 Million
204,880 Added 12.06%
1,903,027 $276 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $24.2 Million - $29.1 Million
-177,089 Reduced 9.44%
1,698,147 $279 Million
Q1 2020

May 15, 2020

SELL
$119.05 - $147.35 $11.3 Million - $14 Million
-95,167 Reduced 4.83%
1,875,236 $266 Million
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $3.23 Million - $4 Million
30,174 Added 1.56%
1,970,403 $259 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $17 Million - $18.4 Million
158,771 Added 8.91%
1,940,229 $218 Million
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $165 Million - $193 Million
-1,493,116 Reduced 45.6%
1,781,458 $197 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $37.7 Million - $44.4 Million
-338,832 Reduced 9.38%
3,274,574 $425 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $9.08 Million - $10.2 Million
-85,776 Reduced 2.32%
3,613,406 $418 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $61.2 Million - $76.5 Million
-712,772 Reduced 16.16%
3,699,182 $397 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $21 Million - $24.1 Million
-277,269 Reduced 5.91%
4,411,954 $377 Million
Q1 2018

May 11, 2018

BUY
$74.21 - $87.6 $177 Million - $209 Million
2,388,548 Added 103.82%
4,689,223 $363 Million
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $84.6 Million - $90.7 Million
1,031,859 Added 81.32%
2,300,675 $194 Million
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $97.8 Million - $109 Million
1,268,816
1,268,816 $108 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.